The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. (PloS one, 2014)

(untitled) - Tameris, M; Geldenhuys, H; Luabeya, A; Smit, E; Hughes, J; Vermaak, S; Hanekom, W; Hatherill, M; Mahomed, H; Mcshane, H; Scriba, T